Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status

• Egile Nagusiak: Thomas B. Casale (Egilea), Ana Maria Gimenez-Arnau (Egilea), Jonathan A. Bernstein (Egilea), Michael Holden (Egilea), Torsten Zuberbier (Egilea), Marcus Maurer (Egilea)
• Formatua: Liburua
• Argitaratua: Adis, Springer Healthcare, 2023-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Chronic spontaneous urticaria (CSU) is a debilitating inflammatory disorder of the skin, characterized by a fluctuating natural history, a complex mechanism of action, and a significant burden on patients, including effect on quality of life, development of psychosocial disorders, and a ran...